Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
7.08
+0.10 (1.43%)
At close: Nov 26, 2025, 4:00 PM EST
7.33
+0.25 (3.53%)
After-hours: Nov 26, 2025, 7:45 PM EST
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $230.25 million as of November 26, 2025. Its market cap has increased by 23.33% in one year.
Market Cap
230.25M
Enterprise Value
104.87M
1-Year Change
23.33%
Ranking
Category
Stock Price
$7.08
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $230.25M, a decrease of -35.10%. That is a compound annual growth rate of -16.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 230.25M | 58.93% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
| Jul 14, 2023 | 354.80M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 989.85B |
| Johnson & Johnson | 498.87B |
| AbbVie | 401.74B |
| UnitedHealth Group | 298.69B |
| AstraZeneca | 288.24B |
| Merck & Co. | 260.86B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.71B |